The European interventional oncology device market will see\u00a0modest\u00a0growth through 2033,\u00a0driven by\u00a0increasing incidence and prevalence rates of cancer, cost-effectiveness of ablation and embolization devices compared to surgery, improved reimbursement, changing guidelines, launch of innovative products, increasing popularity of minimally invasive surgeries, and growing physician acceptance of interventional oncology procedures. However, growth in this market will be\u00a0hindered\u00a0by mixed clinical data, increasing-price competition, and ongoing cost constraints in the region.<\/p>\n
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in Europe from 2019 to 2033.<\/p>\n","protected":false},"template":"","class_list":["post-539782","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-interventional-oncology-devices","medtech-geography-europe","medtech-date-2294"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/539782","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/539782\/revisions"}],"predecessor-version":[{"id":540053,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/539782\/revisions\/540053"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=539782"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}